Good morning :)
Switch to
Place Order

Brooks Laboratories Ltd

BROOKS
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹143 cr, stock is ranked 1,500
Low RiskStock is 1.82x as volatile as Nifty
58.600.40 (+0.68%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹143 cr, stock is ranked 1,500
Low RiskStock is 1.82x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-5.26
PB RatioPB Ratio
1.46
Dividend YieldDiv. Yield
Sector PESector PE
41.26
Sector PBSector PB
5.02
Sector Div YldSctr Div Yld
0.50%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201720182019202057.6655.9557.9170.091.67-13.81-14.80-24.37
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Copy of Newspaper Publication 
Announced OnFeb 12, 2021

Brooks Laboratories Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results for the 3rd quarter ended 31.12.2020 | Download

Brooks Laboratories Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results for the 3rd quarter ended 31.12.2020 | Download

Updates 
Announced OnFeb 11, 2021

Brooks Laboratories Limited has informed the Exchange regarding 'Updates for Modification of Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information'. | Download

Brooks Laboratories Limited has informed the Exchange regarding 'Updates for Modification of Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information'. | Download

See all events